Company Debut Diamonds Inc. Canadian Securities Exchange

Equities

DDI

CA24276X1042

Delayed Canadian Securities Exchange Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-.--%	+48.57%

2021	Made Therapeutics, Inc. completed the acquisition of Debut Diamonds Inc. from Jason I. Goldman Professional Corporation, Marc Lustig, Steven Mintz, Camille Rabay, Rajiv Bhatia,Greg Wilson and others in a reverse merger transaction.	CI
2021	Debut Diamonds Inc. Reports Earnings Results for the Third Quarter Ended January 31, 2021	CI

Business Summary

Wesana Health Holdings Inc, formerly Debut Diamonds Inc. (Debut), is a Canada-based life science company. The Company is engaged in development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain injury (TBI) and related conditions. It develops evidence-based formulations and protocols for patients to overcome neurological, psychological and mental health ailments caused by trauma.

Company contact information

Debut Diamonds, Inc.

141 Adelaide Street West Suite 420

M5H 3L5, Toronto

http://www.debutdiamonds.com/docs/

Sector

This company's sector is not yet available